PL2744831T3 - Białko fuzyjne transferryna-tumstatyna oraz sposoby jego wytwarzania i stosowania - Google Patents
Białko fuzyjne transferryna-tumstatyna oraz sposoby jego wytwarzania i stosowaniaInfo
- Publication number
- PL2744831T3 PL2744831T3 PL12824616T PL12824616T PL2744831T3 PL 2744831 T3 PL2744831 T3 PL 2744831T3 PL 12824616 T PL12824616 T PL 12824616T PL 12824616 T PL12824616 T PL 12824616T PL 2744831 T3 PL2744831 T3 PL 2744831T3
- Authority
- PL
- Poland
- Prior art keywords
- transferrin
- producing
- methods
- same
- fusion protein
- Prior art date
Links
- 108020001507 fusion proteins Proteins 0.000 title 1
- 102000037865 fusion proteins Human genes 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/79—Transferrins, e.g. lactoferrins, ovotransferrins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/20—Fusion polypeptide containing a tag with affinity for a non-protein ligand
- C07K2319/21—Fusion polypeptide containing a tag with affinity for a non-protein ligand containing a His-tag
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/60—Fusion polypeptide containing spectroscopic/fluorescent detection, e.g. green fluorescent protein [GFP]
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Toxicology (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Ophthalmology & Optometry (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161524508P | 2011-08-17 | 2011-08-17 | |
| PCT/US2012/051013 WO2013025846A2 (en) | 2011-08-17 | 2012-08-15 | Transferrin-tumstatin fusion protein and methods for producing and using the same |
| EP12824616.2A EP2744831B1 (en) | 2011-08-17 | 2012-08-15 | Transferrin-tumstatin fusion protein and methods for producing and using the same |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL2744831T3 true PL2744831T3 (pl) | 2018-05-30 |
Family
ID=47715692
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL12824616T PL2744831T3 (pl) | 2011-08-17 | 2012-08-15 | Białko fuzyjne transferryna-tumstatyna oraz sposoby jego wytwarzania i stosowania |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US9290562B2 (pl) |
| EP (1) | EP2744831B1 (pl) |
| JP (1) | JP6073888B2 (pl) |
| CN (2) | CN103998470A (pl) |
| AU (1) | AU2012296588B2 (pl) |
| BR (1) | BR112014008680A2 (pl) |
| CA (1) | CA2849015C (pl) |
| DK (1) | DK2744831T3 (pl) |
| ES (1) | ES2659161T3 (pl) |
| NO (1) | NO2820418T3 (pl) |
| PL (1) | PL2744831T3 (pl) |
| PT (1) | PT2744831T (pl) |
| SI (1) | SI2744831T1 (pl) |
| TR (1) | TR201802686T4 (pl) |
| WO (1) | WO2013025846A2 (pl) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2016520053A (ja) * | 2013-05-06 | 2016-07-11 | 中国▲薬▼科大学Ｃｈｉｎａ Ｐｈａｒｍａｃｅｕｔｉｃａｌ Ｕｎｉｖｅｒｓｉｔｙ | 腫瘍微小環境における血管再生の抑制及び適応免疫応答の活性化を有する二機能の融合タンパク質及びその遺伝子並びに使用 |
| JP2016522249A (ja) * | 2013-06-20 | 2016-07-28 | ノバルティス アーゲー | 脈絡膜血管新生の治療におけるｖｅｇｆアンタゴニストの使用 |
| US11058750B2 (en) | 2015-12-03 | 2021-07-13 | Mor Research Applications Ltd. | Compositions and methods for treatment of ocular diseases |
| KR101818151B1 (ko) | 2016-03-25 | 2018-01-16 | 한국과학기술원 | 트렌스페린을 포함하는 허혈성망막병증 예방 및 치료용 조성물 |
| CN109053899B (zh) * | 2017-12-22 | 2021-11-16 | 湖南远泰生物技术有限公司 | 一种含人转铁蛋白抗原表位序列的嵌合体抗原受体 |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5672683A (en) | 1989-09-07 | 1997-09-30 | Alkermes, Inc. | Transferrin neuropharmaceutical agent fusion protein |
| US20050192242A1 (en) | 1995-10-11 | 2005-09-01 | Neal Zane C. | Therapeutic fusion protein transgenes |
| KR100682666B1 (ko) * | 1998-06-17 | 2007-02-15 | 베쓰 이스라엘 디코니스 메디칼 센터 인크 | 항혈관형성 단백질 및 이들을 사용하는 방법 |
| AU3075801A (en) | 1999-12-23 | 2001-07-03 | Human Genome Sciences, Inc. | Transferrin polynucleotides, polypeptides, and antibodies |
| AU2002323501C1 (en) | 2001-08-30 | 2010-04-29 | Biorexis Technology, Inc | Modified transferrin fusion proteins |
| US8129504B2 (en) * | 2001-08-30 | 2012-03-06 | Biorexis Technology, Inc. | Oral delivery of modified transferrin fusion proteins |
| DK1463751T3 (da) | 2001-12-21 | 2013-08-26 | Human Genome Sciences Inc | Albuminfusionsproteiner. |
| WO2003066085A1 (en) * | 2002-02-07 | 2003-08-14 | Delta Biotechnology Limited | Albumin-fused anti-angiogenesis peptides |
| WO2005034877A2 (en) | 2003-10-10 | 2005-04-21 | University Of Southern California | G-csf transferrin fusion proteins |
| EP1722762A2 (en) * | 2004-03-02 | 2006-11-22 | Massachusetts Institute of Technology | Nanocell drug delivery system |
| CA2583399A1 (en) * | 2004-10-14 | 2006-04-27 | Sopherion Therapeutics, Inc. | Anti-angiogenic peptides and methods of use thereof |
| WO2006049983A2 (en) | 2004-10-27 | 2006-05-11 | Biorexis Pharmaceutical Corporation | Peptide yy modified transferrin fusion proteins |
| US20070025957A1 (en) * | 2005-04-29 | 2007-02-01 | Rosenblum Michael G | Vascular targeting of ocular neovascularization |
| AU2007211846B2 (en) | 2006-02-03 | 2013-05-23 | The University Of Sydney | A method of modulating cellular activity and agents for use therein |
| CN101070349B (zh) * | 2007-05-22 | 2010-10-13 | 山西康宝生物制品股份有限公司 | 具有选择性杀伤肿瘤新生血管内皮细胞作用的融合蛋白与应用 |
| CN101092452A (zh) * | 2007-05-23 | 2007-12-26 | 哈尔滨医科大学 | 肿瘤抑素抗血管生成小分子多肽、融合蛋白及两者制备方法 |
| WO2009086132A2 (en) * | 2007-12-20 | 2009-07-09 | University Of Southern California | Design of spacers to increase the expression of recombinant fusion proteins |
| AU2012222833B2 (en) | 2011-03-03 | 2017-03-16 | Zymeworks Inc. | Multivalent heteromultimer scaffold design and constructs |
-
2012
- 2012-08-15 DK DK12824616.2T patent/DK2744831T3/en active
- 2012-08-15 CN CN201280051256.4A patent/CN103998470A/zh active Pending
- 2012-08-15 US US14/239,176 patent/US9290562B2/en active Active
- 2012-08-15 PL PL12824616T patent/PL2744831T3/pl unknown
- 2012-08-15 CN CN201910156923.9A patent/CN110105453A/zh active Pending
- 2012-08-15 PT PT128246162T patent/PT2744831T/pt unknown
- 2012-08-15 CA CA2849015A patent/CA2849015C/en active Active
- 2012-08-15 AU AU2012296588A patent/AU2012296588B2/en active Active
- 2012-08-15 BR BR112014008680A patent/BR112014008680A2/pt unknown
- 2012-08-15 WO PCT/US2012/051013 patent/WO2013025846A2/en active Application Filing
- 2012-08-15 JP JP2014526189A patent/JP6073888B2/ja active Active
- 2012-08-15 ES ES12824616.2T patent/ES2659161T3/es active Active
- 2012-08-15 SI SI201231232T patent/SI2744831T1/en unknown
- 2012-08-15 TR TR2018/02686T patent/TR201802686T4/tr unknown
- 2012-08-15 EP EP12824616.2A patent/EP2744831B1/en active Active
-
2013
- 2013-07-22 NO NO13745268A patent/NO2820418T3/no unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AU2012296588A1 (en) | 2014-04-03 |
| EP2744831B1 (en) | 2017-12-06 |
| WO2013025846A3 (en) | 2013-05-02 |
| CN110105453A (zh) | 2019-08-09 |
| CA2849015C (en) | 2017-08-08 |
| WO2013025846A2 (en) | 2013-02-21 |
| US9290562B2 (en) | 2016-03-22 |
| NO2820418T3 (pl) | 2018-05-05 |
| JP6073888B2 (ja) | 2017-02-01 |
| AU2012296588B2 (en) | 2017-07-27 |
| JP2014526890A (ja) | 2014-10-09 |
| EP2744831A2 (en) | 2014-06-25 |
| EP2744831A4 (en) | 2015-03-11 |
| DK2744831T3 (en) | 2018-03-05 |
| ES2659161T3 (es) | 2018-03-14 |
| PT2744831T (pt) | 2018-03-05 |
| TR201802686T4 (tr) | 2018-03-21 |
| SI2744831T1 (en) | 2018-04-30 |
| CN103998470A (zh) | 2014-08-20 |
| US20140179612A1 (en) | 2014-06-26 |
| CA2849015A1 (en) | 2013-02-21 |
| BR112014008680A2 (pt) | 2017-06-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1208476A1 (en) | Anti-b7-h6 antibody, fusion proteins, and methods of using the same b7-h6 | |
| IL240898A0 (en) | Antibodies against a5c and methods of using the antibodies | |
| PT2697187T (pt) | Olefinas e métodos para produção das mesmas | |
| HK1192587A1 (zh) | 治療性融合蛋白 | |
| EP2877854A4 (en) | FUSION PROTEINS AND METHOD THEREFOR | |
| GB201115280D0 (en) | Antibodies, uses and methods | |
| LT3321287T (lt) | Sulieti baltymai ir sudėtinės vakcinos | |
| IL232743A0 (en) | anticancer fusion protein | |
| IL233757A0 (en) | Anti '1m e-gi antibodies and methods of using them | |
| ZA201400562B (en) | Axmi205 variant proteins and methods for their use | |
| EP2842969A4 (en) | LACTOFERRIN BASED FUSION PROTEIN AND PROCESS FOR PRODUCING THE SAME | |
| SG10201604332XA (en) | Membrane and method for making the same | |
| SG10201500208SA (en) | Npp1 fusion proteins | |
| IL232834A0 (en) | anticancer fusion protein | |
| EP2711376A4 (en) | FGFR-FC FUSION PROTEIN AND USE THEREOF | |
| EP2698386B8 (en) | Fusion protein | |
| EP2683742A4 (en) | NPP1 FUSION PROTEIN | |
| EP2657337A4 (en) | FUSION PROTEIN | |
| EP2718432A4 (en) | NUCLEASE FUSION PROTEIN AND USES THEREOF | |
| PT2744831T (pt) | Proteína de fusão de transferrina-tumstatina e métodos para a produzir e utilizar | |
| HK1158029A1 (en) | Cystine-containing complex and method for producing the same | |
| ZA201207425B (en) | Fusion protein | |
| EP2771351A4 (en) | PAT-LM1 EPITOPES AND METHODS OF USE | |
| GB201114701D0 (en) | Fusion proteins | |
| GB201107189D0 (en) | Fusion proteins |